RRN3P1
Putative RRN3-like protein RRN3P1
Also known as: RN3P1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for RRN3P1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
152 residues, UniProt reviewed canonical sequence.
>Q2M238|RRN3P1
1 MGFAEAFLEH LWKNLQDPSN PAIIRQAAGN YIGSFLARAK FISLITVKPC LDLLVNWLHI
61 YLNNQDSGTK AFCDVALHGP FYSACQAVFY TFVFRHKQLL SGNLKEGLQY PQSLNFERIV
121 MSQLNPLKIC LPSVVNFFAA ITKMKTCGYG WWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RRN3P1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RRN3P1 as an antibody target. Whether an autoantibody or antibody against RRN3P1 could matter depends on whether native RRN3P1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RRN3P1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RRN3P1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...